Understanding FDA labeling guidance, your lifestyle factors, and how timing affects side effects will help you and your healthcare provider determine the optimal schedule for your GLP-1 therapy
Heres what current studies show: People taking the highest dose of retatrutide (12 mg) in the latest phase 3 trial lost an average of about 24% of their body weight in about 68 weeks
They operate under different regulations, use different processes, and produce different types of products
GLP-1, GIP & Inflammation: What These Medications Really Do and What They Dont Joshua Silva, MD Dec 5, 2025 7 min read Updated: Jan 27 Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Quick Answer GLP-1 and GLP-1/GIP medications (such as semaglutide and tirzepatide ) can lower metabolic inflammation by improving insulin resistance, reducing visceral fat, and lowering inflammatory biomarkers such as C-reactive protein (CRP) ., They can also improve cardiometabolic risk markers (e.g., blood pressure) and, for tirzepatide, can improve atherogenic lipoprotein measures including apoB and triglyceride-rich lipoproteins in clinical research settings., They do not treat autoimmune diseases or fibromyalgia directly
Some patients benefit from micro-dosing protocols or lower maintenance doses that still deliver weight loss benefits with fewer GI symptoms
This continuous support and fine-tuning ensure that you are always on the right track and getting the most out of your therapy